Comparative gene expression profiling of placentas from patients with severe pre-eclampsia and unexplained fetal growth restriction

Reproductive Biology and Endocrinology

Volumn 9, Issue , 2011, Pages

  Nishizawa, Haruki ^a   Ota, Sayuri ^b   Suzuki, Machiko ^b   Kato, Takema ^b   Sekiya, Takao ^a   Kurahashi, Hiroki ^b   Udagawa, Yasuhiro ^a  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b FUJITA HEALTH UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BAX; PROTEIN BCL 6; VASCULOTROPIN RECEPTOR 1; PROTEIN P53; TP53 PROTEIN, HUMAN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENG GENE; FEMALE; GENE; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; INTRAUTERINE GROWTH RETARDATION; PLACENTA; PREECLAMPSIA; PREGNANCY; UPREGULATION; GENE EXPRESSION PROFILING; GENETICS; METABOLISM; MICROARRAY ANALYSIS;

FEMALE; FETAL GROWTH RETARDATION; GENE EXPRESSION PROFILING; HUMANS; MICROARRAY ANALYSIS; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; TUMOR SUPPRESSOR PROTEIN P53;

EID: 79960893393     PISSN: None     EISSN: 14777827     Source Type: Journal    
DOI: 10.1186/1477-7827-9-107     Document Type: Article

References (62)

1. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 2005, 365:785-799.
2. Hall DR, Odendaal HJ, Steyn DW, Grove D. Expectant management of early onset, severe pre-eclampsia: maternal outcome. BJOG 2000, 107:1252-1257. 10.1111/j.1471-0528.2000.tb11616.x, 11028577.
3. Roberts JM, Cooper DW. Pathogenesis and genetics of pre-eclampsia. Lancet 2001, 357:53-56. 10.1016/S0140-6736(00)03577-7, 11197372.
4. Woodage T, Venter JC, Broder S. Application of the human genome to obstetrics and gynecology. Clin Obstet Gynecol 2002, 45:711-732. 10.1097/00003081-200209000-00014, 12370610.
5. Kanter D, Lindheimer MD, Wang E, Borromeo RG, Bousfield E, Karumanchi SA, Stillman IE. Angiogenic dysfunction in molar pregnancy. Am J Obstet Gynecol 2010, 202:184.e1-5.
6. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004, 350:672-683. 10.1056/NEJMoa031884, 14764923.
7. Venkatesha S, Toporsian M, Lam C, Hanai J, Mammoto T, Kim YM, Bdolah Y, Lim KH, Yuan HT, Libermann TA, Stillman IE, Roberts D, D'Amore PA, Epstein FH, Sellke FW, Romero R, Sukhatme VP, Letarte M, Karumanchi SA. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 2006, 12:642-649. 10.1038/nm1429, 16751767.
8. Cetin I, Alvino G. Intrauterine growth restriction: implications for placental metabolism and transport. A review. Placenta 2009, 30(Suppl A):S77-82.
9. Villar J, Carroli G, Wojdyla D, Abalos E, Giordano D, Ba'aqeel H, Farnot U, Bergsjø P, Bakketeig L, Lumbiganon P, Campodónico L, Al-Mazrou Y, Lindheimer M, Kramer M, . World Health Organization Antenatal Care Trial Research Group Preeclampsia, gestational hypertension and intrauterine growth restriction, related or independent conditions?. Am J Obstet Gynecol 2006, 194:921-931. 10.1016/j.ajog.2005.10.813, 16580277, World Health Organization Antenatal Care Trial Research Group.
10. Kaufmann P, Black S, Huppertz B. Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia. Biol Reprod 2003, 69:1-7. 10.1095/biolreprod.102.014977, 12620937.
11. Mayhew TM, Ohadike C, Baker PN, Crocker IP, Mitchell C, Ong SS. Stereological investigation of placental morphology in pregnancies complicated by pre-eclampsia with and without intrauterine growth restriction. Placenta 2003, 24:219-226. 10.1053/plac.2002.0900, 12566249.
12. Egbor M, Ansari T, Morris N, Green CJ, Sibbons PD. Morphometric placental villous and vascular abnormalities in early- and late-onset pre-eclampsia with and without fetal growth restriction. BJOG 2006, 113:580-589. 10.1111/j.1471-0528.2006.00882.x, 16579806.
13. Cross JC. The genetics of pre-eclampsia: a feto-placental or maternal problem?. Clin Genet 2003, 64:96-103. 10.1034/j.1399-0004.2003.00127.x, 12859402.
14. ACOG Committee on Obstetric Practice ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Int J Gynaecol Obstet 2002, 77:67-75. ACOG Committee on Obstetric Practice.
15. Ogawa Y, Iwamura T, Kuriya N, Nishida H, Takeuchi H, Takada M, Itabashi K, Imura S, Isobe K. Birth size standards by gestational age for Japanese neonates. Acta Neonat Jap 1998, 34:624-632.
16. Nishizawa H, Pryor-Koishi K, Kato T, Kowa H, Kurahashi H, Udagawa Y. Microarray analysis of differentially expressed fetal genes in placental tissue derived from early and late onset severe pre-eclampsia. Placenta 2007, 28:487-497. 10.1016/j.placenta.2006.05.010, 16860862.
17. Brazma A, Hingamp P, Quackenbush J, Sherlock G, Spellman P, Stoeckert C, Aach J, Ansorge W, Ball CA, Causton HC, Gaasterland T, Glenisson P, Holstege FC, Kim IF, Markowitz V, Matese JC, Parkinson H, Robinson A, Sarkans U, Schulze-Kremer S, Stewart J, Taylor R, Vilo J, Vingron M. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet 2001, 29:365-371. 10.1038/ng1201-365, 11726920.
18. Kim PM, Tidor B. Subsystem identification through dimensionality reduction of large-scale gene expression data. Genome Res 2003, 13:1706-1718. 10.1101/gr.903503, 403744, 12840046.
19. Brunet JP, Tamayo P, Golub TR, Mesirov JP. Metagenes and molecular pattern discovery using matrix factorization. Proc Natl Acad Sci USA 2004, 101:4164-4169. 10.1073/pnas.0308531101, 384712, 15016911.
20. Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, Puigserver P, Carlsson E, Ridderstråle M, Laurila E, Houstis N, Daly MJ, Patterson N, Mesirov JP, Golub TR, Tamayo P, Spiegelman B, Lander ES, Hirschhorn JN, Altshuler D, Groop LC. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 2003, 34:267-273. 10.1038/ng1180, 12808457.
21. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005, 102:15545-15550. 10.1073/pnas.0506580102, 1239896, 16199517.
22. Gene Set Enrichment Analysis (GSEA). , http://www.broad.mit.edu/gsea/
23. Muttukrishna S, Knight PG, Groome NP, Redman CW, Ledger WL. Activin A and inhibin A as possible endocrine markers for pre-eclampsia. Lancet 1997, 349:1285-1288. 10.1016/S0140-6736(96)09264-1, 9142063.
24. Pryor-Koishi K, Nishizawa H, Kato T, Kogo H, Murakami T, Tsuchida K, Kurahashi H, Udagawa Y. Overproduction of the follistatin-related gene protein in the placenta and maternal serum of women with pre-eclampsia. BJOG 2007, 114:1128-1137. 10.1111/j.1471-0528.2007.01425.x, 17617189.
25. McCarthy JF, Misra DN, Roberts JM. Maternal plasma leptin is increased in preeclampsia and positively correlates with fetal cord concentration. Am J Obstet Gynecol 1999, 180:731-736. 10.1016/S0002-9378(99)70280-2, 10076155.
26. Nishizawa H, Pryor-Koishi K, Suzuki M, Kato T, Kogo H, Sekiya T, Kurahashi H, Udagawa Y. Increased levels of pregnancy-associated plasma protein-A2 in the serum of pre-eclamptic patients. Mol Hum Reprod 2008, 14:595-602. 10.1093/molehr/gan054, 18805800.
27. Sartipy P, Loskutoff DJ. Expression profiling identifies genes that continue to respond to insulin in adipocytes made insulin-resistant by treatment with tumor necrosis factor-alpha. J Biol Chem 2003, 278:52298-52306. 10.1074/jbc.M306922200, 14530283.
28. Kannan K, Amariglio N, Rechavi G, Jakob-Hirsch J, Kela I, Kaminski N, Getz G, Domany E, Givol D. DNA microarrays identification of primary and secondary target genes regulated by p53. Oncogene 2001, 20:2225-2234. 10.1038/sj.onc.1204319, 11402317.
29. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi SA. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003, 111:649-658. 151901, 12618519.
30. Enquobahrie DA, Meller M, Rice K, Psaty BM, Siscovick DS, Williams MA. Differential placental gene expression in preeclampsia. Am J Obstet Gynecol 2008, 199:566.e1-11.
31. Roh CR, Budhraja V, Kim HS, Nelson DM, Sadovsky Y. Microarray-based identification of differentially expressed genes in hypoxic term human trophoblasts and in placental villi of pregnancies with growth restricted fetuses. Placenta 2005, 26:319-328. 10.1016/j.placenta.2004.06.013, 15823618.
32. Okamoto A, Endo H, Kalionis B, Shinya M, Saito M, Nikaido T, Tanaka T. IGFBP1 and Follistatin-like 3 genes are significantly up-regulated in expression profiles of the IUGR placenta. Placenta 2006, 27:317-321. 10.1016/j.placenta.2004.12.007, 16338475.
33. McCarthy C, Cotter FE, McElwaine S, Twomey A, Mooney EE, Ryan F, Vaughan J. Altered gene expression patterns in intrauterine growth restriction: potential role of hypoxia. Am J Obstet Gynecol 2007, 196:70.e1-6.
34. Struwe E, Berzl G, Schild R, Blessing H, Drexel L, Hauck B, Tzschoppe A, Weidinger M, Sachs M, Scheler C, Schleussner E, Dötsch J. Microarray analysis of placental tissue in intrauterine growth restriction. Clin Endocrinol 2010, 72:241-247.
35. Wyatt SM, Kraus FT, Roh CR, Elchalal U, Nelson DM, Sadovsky Y. The correlation between sampling site and gene expression in the term human placenta. Placenta 2005, 26:372-379. 10.1016/j.placenta.2004.07.003, 15850641.
36. Tzschoppe AA, Struwe E, Dörr HG, Goecke TW, Beckmann MW, Schild RL, Dötsch J. Differences in gene expression dependent on sampling site in placental tissue of fetuses with intrauterine growth restriction. Placenta 2010, 31:178-185. 10.1016/j.placenta.2009.12.002, 20045557.
37. Vaiman D, Mondon F, Garcès-Duran A, Mignot TM, Robert B, Rebourcet R, Jammes H, Chelbi ST, Quetin F, Marceau G, Sapin V, Piumi F, Danan JL, Rigourd V, Carbonne B, Ferré F. Hypoxia-activated genes from early placenta are elevated in preeclampsia, but not in Intra-Uterine Growth Retardation. BMC Genomics 2005, 6:111. 10.1186/1471-2164-6-111, 1236921, 16129025.
38. Toft JH, Lian IA, Tarca AL, Erez O, Espinoza J, Eide IP, Bjørge L, Draghici S, Romero R, Austgulen R. Whole-genome microarray and targeted analysis of angiogenesis-regulating gene expression (ENG, FLT1, VEGF, PlGF) in placentas from pre-eclamptic and small-for-gestational-age pregnancies. J Matern Fetal Neonatal Med 2008, 21:267-273. 10.1080/14767050801924118, 18330824.
39. An WG, Kanekal M, Simon MC, Maltepe E, Blagosklonny MV, Neckers LM. Stabilization of wild-type p53 by hypoxia-inducible factor 1alpha. Nature 1998, 392:405-408. 10.1038/32925, 9537326.
40. Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA, Hoffman B, Reed JC. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 1994, 9:1799-1805.
41. Albagli-Curiel O. Ambivalent role of BCL6 in cell survival and transformation. Oncogene 2003, 22:507-516. 10.1038/sj.onc.1206152, 12555064.
42. Levy R, Nelson DM. To be, or not to be, that is the question. Apoptosis in human trophoblast. Placenta 2000, 21:1-13. 10.1053/plac.1999.0450, 10692245.
43. Jeschke U, Schiessl B, Mylonas I, Kunze S, Kuhn C, Schulze S, Friese K, Mayr D. Expression of the proliferation marker Ki-67 and of p53 tumor protein in trophoblastic tissue of preeclamptic, HELLP, and intrauterine growth-restricted pregnancies. Int J Gynecol Pathol 2006, 25:354-360. 10.1097/01.pgp.0000225838.29127.6, 16990712.
44. Allaire AD, Ballenger KA, Wells SR, McMahon MJ, Lessey BA. Placental apoptosis in preeclampsia. Obstet Gynecol 2000, 96:271-276. 10.1016/S0029-7844(00)00895-4, 10908776.
45. Leung DN, Smith SC, To KF, Sahota DS, Baker PN. Increased placental apoptosis in pregnancies complicated by preeclampsia. Am J Obstet Gynecol 2001, 184:1249-1250. 10.1067/mob.2001.112906, 11349196.
46. Stepan H, Geide A, Faber R. Soluble fms-like tyrosine kinase 1. N Engl J Med 2004, 351:2241-2242. 10.1056/NEJM200411183512123, 15548791.
47. Stepan H, Krämer T, Faber R. Maternal plasma concentrations of soluble endoglin in pregnancies with intrauterine growth restriction. J Clin Endocrinol Metab 2007, 92:2831-2834. 10.1210/jc.2006-2774, 17426082.
48. Nevo O, Many A, Xu J, Kingdom J, Piccoli E, Zamudio S, Post M, Bocking A, Todros T, Caniggia I. Placental expression of soluble fms-like tyrosine kinase 1 is increased in singletons and twin pregnancies with intrauterine growth restriction. J Clin Endocrinol Metab 2008, 93:285-292.
49. Yinon Y, Nevo O, Xu J, Many A, Rolfo A, Todros T, Post M, Caniggia I. Severe intrauterine growth restriction pregnancies have increased placental endoglin levels: hypoxic regulation via transforming growth factor-beta 3. Am J Pathol 2008, 172:77-85. 10.2353/ajpath.2008.070640, 2189618, 18156205.
50. Shibata E, Rajakumar A, Powers RW, Larkin RW, Gilmour C, Bodnar LM, Crombleholme WR, Ness RB, Roberts JM, Hubel CA. Soluble fms-like tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-for-gestational-age neonates: relationship to circulating placental growth factor. J Clin Endocrinol Metab 2005, 90:4895-4903. 10.1210/jc.2004-1955, 15886253.
51. Jeyabalan A, McGonigal S, Gilmour C, Hubel CA, Rajakumar A. Circulating and placental endoglin concentrations in pregnancies complicated by intrauterine growth restriction and preeclampsia. Placenta 2008, 29:555-563. 10.1016/j.placenta.2008.03.006, 2467513, 18462791.
52. Rajakumar A, Jeyabalan A, Markovic N, Ness R, Gilmour C, Conrad KP. Placental HIF-1 alpha, HIF-2 alpha, membrane and soluble VEGF receptor-1 proteins are not increased in normotensive pregnancies complicated by late-onset intrauterine growth restriction. Am J Physiol Regul Integr Comp Physiol 2007, 293:766-774.
53. Crocker I. Gabor Than Award Lecture 2006: pre-eclampsia and villous trophoblast turnover: perspectives and possibilities. Placenta 2007, 28:S4-13.
54. Huppertz B, Frank HG, Kingdom JC, Reister F, Kaufmann P. Villous cytotrophoblast regulation of the syncytial apoptotic cascade in the human placenta. Histochem Cell Biol 1998, 110:495-508. 10.1007/s004180050311, 9826129.
55. Mayhew TM, Leach L, McGee R, Ismail WW, Myklebust R, Lammiman MJ. Proliferation, differentiation and apoptosis in villous trophoblast at 13-41 weeks of gestation (including observations on annulate lamellae and nuclear pore complexes). Placenta 1999, 20:407-422.
56. Goswami D, Tannetta DS, Magee LA, Fuchisawa A, Redman CW, Sargent IL, von Dadelszen P. Excess syncytiotrophoblast microparticle shedding is a feature of early-onset pre-eclampsia, but not normotensive intrauterine growth restriction. Placenta 2006, 27:56-61.
57. Sargent IL, Germain SJ, Sacks GP, Kumar S, Redman CW. Trophoblast deportation and the maternal inflammatory response in pre-eclampsia. J Reprod Immunol 2003, 59:153-160. 10.1016/S0165-0378(03)00044-5, 12896819.
58. Heazell AE, Crocker IP. Live and let die - regulation of villous trophoblast apoptosis in normal and abnormal pregnancies. Placenta 2008, 29:772-783. 10.1016/j.placenta.2008.07.003, 18706691.
59. Smith SC, Baker PN, Symonds EM. Increased placental apoptosis in intrauterine growth restriction. Am J Obstet Gynecol 1997, 177:1395-1401. 10.1016/S0002-9378(97)70081-4, 9423741.
60. Levy R, Smith SD, Yusuf K, Huettner PC, Kraus FT, Sadovsky Y, Nelson DM. Trophoblast apoptosis from pregnancies complicated by fetal growth restriction is associated with enhanced p53 expression. Am J Obstet Gynecol 2002, 186:1056-1061. 10.1067/mob.2002.122250, 12015537.
61. Axt R, Kordina AC, Meyberg R, Reitnauer K, Mink D, Schmidt W. Immunohistochemical evaluation of apoptosis in placentae from normal and intrauterine growth-restricted pregnancies. Clin Exp Obstet Gynecol 1999, 26:195-198.
62. Ishihara N, Matsuo H, Murakoshi H, Laoag-Fernandez JB, Samoto T, Maruo T. Increased apoptosis in the syncytiotrophoblast in human term placentas complicated by either preeclampsia or intrauterine growth retardation. Am J Obstet Gynecol 2002, 186:158-166. 10.1067/mob.2002.119176, 11810103.